Ohcanbohtosat - Müller Dj
- Čájehuvvo 1 - 7 / 7
-
1
Pharmacogenetics of antipsychotic treatment response and side effects Dahkki Mackenzie, B, Souza, RP, Likhodi, O, Tiwari, AK, Zai, CC, Sturgess, J, Müller, DJ
Almmustuhtton 2010Teaksta -
2
Clinical pharmacogenetics implementation consortium guideline (CPIC) for <i>CYP2D6</i> and <i>CYP2C19</i> genotypes and dosing of tricyclic antidepressants: 2016 update Dahkki JK Hicks, Katrin Sangkuhl, JJ Swen, VL Ellingrod, Müller Dj, Kazutaka Shimoda, JR Bishop, E D Kharasch, TC Skaar, Andrea Gaedigk, Henry M. Dunnenberger, Teri E. Klein, KE Caudle, Julia Stingl
Almmustuhtton 2016Artigo -
3
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors Dahkki Hicks, JK, Bishop, JR, Sangkuhl, K, Müller, DJ, Ji, Y, Leckband, SG, Leeder, JS, Graham, RL, Chiulli, DL, LLerena, A, Skaar, TC, Scott, SA, Stingl, JC, Klein, TE, Caudle, KE, Gaedigk, A
Almmustuhtton 2015Teaksta -
4
Getting to Precision Psychopharmacology: Combining Clinical and Genetic Information to Predict Fat Gain from Aripiprazole Dahkki Oughli, H., Lenze, E.J., Locke, A.E., Yingling, M.D., Zhong, Y., Miller, J.P., Reynolds, C.F., Mulsant, B.H., Newcomer, J. W., Peterson, T.R., Müller, D.J., Nicol, G.E.
Almmustuhtton 2019Teaksta -
5
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and <i>CYP2C19</i> Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors Dahkki J K Hicks, JR Bishop, Katrin Sangkuhl, Müller Dj, Yuan Ji, SG Leckband, JS Leeder, RL Graham, DL Chiulli, Adrián LLerena, TC Skaar, Stuart A. Scott, Julia Stingl, Teri E. Klein, KE Caudle, Andrea Gaedigk
Almmustuhtton 2015Artigo -
6
The nucleus acts as a ruler tailoring cell responses to spatial constraints Dahkki Lomakin, A.J., Cattin, C.J., Cuvelier, D., Alraies, Z., Molina, M., Nader, G.P.F., Srivastava, N., Saez, P.J., Garcia-Arcos, J.M., Zhitnyak, I.Y., Bhargava, A., Driscoll, M.K., Welf, E.S., Fiolka, R., Petrie, R.J., De Silva, N.S., González-Granado, J.M., Manel, N., Lennon-Duménil, A.M., Müller, D.J., Piel, M.
Almmustuhtton 2020Teaksta -
7
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting Dahkki LV Kalman, José A. G. Agúndez, Malin Lindqvist Appell, J.H. Black, GC Bell, Sotiria Boukouvala, Carsten Bruckner, Elspeth A. Bruford, KE Caudle, SA Coulthard, Ann K. Daly, AL Del Tredici, Johan T. den Dunnen, Katarzyna Drozda, Robin E. Everts, David A. Flockhart, Robert R. Freimuth, Andrea Gaedigk, Houda Hachad, Toinette Hartshorne, Magnus Ingelman‐Sundberg, Teri E. Klein, Volker M. Lauschke, DR Maglott, HL McLeod, GA McMillin, Meyer Ua, Müller Dj, D. A. Nickerson, WS Oetting, MA Pacanowski, Pratt Vm, MV Relling, Angharad M. Roberts, Rubinstein Ws, Katrin Sangkuhl, Matthias Schwab, Stuart A. Scott, SC Sim, RK Thirumaran, LH Toji, Rachel F. Tyndale, RHN van Schaik, Michelle Whirl‐Carrillo, K. L. B. Yeo, UM Zanger
Almmustuhtton 2015Revisão
Ohcanreaiddut:
Laktáseaddji fáttát
Biology
Gene
Genotype
Medicine
Pharmacogenetics
CYP2C19
CYP2D6
Cytochrome P450
Dosing
Genetics
Internal medicine
Metabolism
Pharmacology
Antidepressant
Anxiety
Biochemistry
Botany
Chemical nomenclature
Chemistry
Citalopram
Computational biology
Computer network
Computer science
Computer security
Confusion
Escitalopram
Fluoxetine
Fluvoxamine
Guideline
Nomenclature